PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K

What Happened
On May 7, 2026, Pacific Biosciences of California, Inc. announced its financial results for the first fiscal quarter ended March 31, 2026. The announcement was made via a press release that the company furnished as Exhibit 99.1 to a Form 8‑K (Item 2.02). The 8‑K furnishes the press release (incorporated by reference) but does not itself contain the detailed financial figures.

Key Details

• Filing date: May 7, 2026 (Form 8‑K).
• Reporting period: First fiscal quarter ended March 31, 2026.
• Item reported: 2.02 (Results of Operations and Financial Condition); related press release furnished as Exhibit 99.1.
• The press release is "furnished and not filed" with the SEC (standard treatment limiting incorporation by reference).

Why It Matters
This filing signals that PacBio has released its quarterly earnings/quarterly results and investors should review the attached press release for revenue, earnings, guidance, and other material financial details. The Form 8‑K itself does not present the numbers, so to assess impact on revenue, profitability, or outlook you should read the Exhibit 99.1 press release and any subsequent filings (e.g., 10‑Q) the company may provide.